Improving communication for Spanish-speaking families with cancer
Official title: Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
Run by University of Colorado, Denver · NCT05425992 · Data updated 2026-11-12
This study is trying to improve communication and support for Spanish-speaking families dealing with leukemia or non-Hodgkin lymphoma to help them feel more included and better understand their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 22 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | March 17, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT05425992 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Spanish-speaking patients aged 0 to 22 years diagnosed with leukemia or non-Hodgkin lymphoma who are receiving care at the Center for Cancer and Blood Disorders.
✕Probably not a fit
Patients without an oncologic diagnosis or those whose parents prefer English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance communication with Spanish-speaking families of patients diagnosed with leukemia or non-Hodgkin lymphoma. The study focuses on increasing the sense of inclusion within the medical community, improving medical knowledge and understanding, and enhancing adherence to treatment regimens. By conducting interviews, the study seeks to address gaps in care and promote equality in the delivery of comprehensive medical services across both physical and psychosocial domains.
Why it matters
Potential benefit: If successful, this study could lead to better health outcomes and improved quality of care for Spanish-speaking families dealing with cancer.
How similar studies have gone: While there may be similar studies focusing on communication in healthcare, this specific approach targeting Spanish-speaking families in oncology is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 0 to 22 years of age * Diagnosis of leukemia or non-Hodgkin lymphoma * Spanish as preferred language for patient, parent or guardian * Received or receiving care at the Center for Cancer and Blood Disorders (CCBD) Exclusion Criteria: * Patients without oncologic diagnosis * Patients with parents whose language preference is English * Patients who received care solely outside of the CCBD
Where it's running
-
Children's Hospital Colorado
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Ashley Rogers — Children's Hospital Colorado
- Study coordinator: Wendy Moore
- Email: wendy.moore@childrenscolorado.org
- Phone: 1-720-777-6353
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cord blood transplant for children and young adults with blood cancers.
This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.
-
See if a behavioral coaching plus at-home exercise can help older blood cancer survivors slow aging
Aimed at people 50 and older who have had a blood cancer, this trial tests whether combining coaching with a virtual exercise program can help slow aging and improve health.
-
Evaluating the risk of blood cancers in firefighters
This study is testing if firefighters who have been exposed to harmful substances are at a higher risk for blood cancers and related conditions.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
-
Study of crushed venetoclax tablets dissolved in liquid for pediatric patients
This study tests if crushing venetoclax tablets and mixing them with liquid helps children with blood cancers absorb the medication better and stay safe while taking it.
-
Investigating cognitive impairment in young cancer patients during and after chemotherapy
This study is testing how chemotherapy affects memory and attention in children and young adults with cancer to better understand their cognitive challenges during and after treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.